Rare Pathogenic Mutations (RPMs)
Rare Pathogenic Mutations (RPMs) are pathogenic DNA mutations in the coding regions of genes known to be associated with prostate cancer, such as ATM, BRCA2, and CHEK2. RPMs are associated with both an increased risk for developing prostate cancer and more aggressive tumor behavior.